These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 15040539

  • 1. Intracellular and plasma pharmacokinetics of nelfinavir and M8 in HIV-infected patients: relationship with P-glycoprotein expression.
    Ford J, Cornforth D, Hoggard PG, Cuthbertson Z, Meaden ER, Williams I, Johnson M, Daniels E, Hsyu P, Back DJ, Khoo SH.
    Antivir Ther; 2004 Feb; 9(1):77-84. PubMed ID: 15040539
    [Abstract] [Full Text] [Related]

  • 2. Intracellular accumulation of nelfinavir and its relationship to P-glycoprotein expression and function in HIV-infected patients.
    Hennessy M, Clarke S, Spiers JP, Kelleher D, Mulcahy F, Hoggard P, Back D, Barry M.
    Antivir Ther; 2004 Feb; 9(1):115-22. PubMed ID: 15040543
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum.
    van Heeswijk RP, Khaliq Y, Gallicano KD, Bourbeau M, Seguin I, Phillips EJ, Cameron DW.
    Clin Pharmacol Ther; 2004 Dec; 76(6):588-97. PubMed ID: 15592330
    [Abstract] [Full Text] [Related]

  • 6. Population pharmacokinetics and pharmacodynamics of nelfinavir and its active metabolite M8 in HIV-1-infected children.
    Crommentuyn KM, Scherpbier HJ, Kuijpers TW, Mathôt RA, Huitema AD, Beijnen JH.
    Pediatr Infect Dis J; 2006 Jun; 25(6):538-43. PubMed ID: 16732153
    [Abstract] [Full Text] [Related]

  • 7. Saquinavir, nelfinavir and M8 pharmacokinetics following combined saquinavir, ritonavir and nelfinavir administration.
    Stocker H, Herzmann C, Breske A, Kruse G, Berger M, Schulbin H, Hill A, Steinmüller J, Becker M, Arastéh K, Kurowski M.
    J Antimicrob Chemother; 2007 Mar; 59(3):560-4. PubMed ID: 17255144
    [Abstract] [Full Text] [Related]

  • 8. Elevated plasma concentrations of protease inhibitors and nonnucleoside reverse transcriptase inhibitors in patients coinfected with human immunodeficiency virus and hepatitis B or C: case series and literature review.
    Robertson SM, Scarsi KK, Postelnick MJ, Lynch P.
    Pharmacotherapy; 2005 Aug; 25(8):1068-72. PubMed ID: 16207097
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and tolerability of a combination of indinavir, lopinavir and ritonavir in multiply pretreated HIV-1 infected adults.
    von Hentig N, Müller A, Rottmann C, Lutz T, Klauke S, Kurowski M, Staszewski S, Harder S.
    Eur J Med Res; 2006 Jun 30; 11(6):236-44. PubMed ID: 16820336
    [Abstract] [Full Text] [Related]

  • 10. The steady-state pharmacokinetics of nelfinavir in combination with tenofovir in HIV-infected patients.
    Kruse G, Esser S, Stocker H, Breske A, Koerber A, Kopperman M, Wiehler H, Ross B, Möcklinghoff C, Hill A, Becker M, Kurowski M.
    Antivir Ther; 2005 Jun 30; 10(2):349-55. PubMed ID: 15865230
    [Abstract] [Full Text] [Related]

  • 11. Pregnancy-related effects on nelfinavir-M8 pharmacokinetics: a population study with 133 women.
    Hirt D, Treluyer JM, Jullien V, Firtion G, Chappuy H, Rey E, Pons G, Mandelbrot L, Urien S.
    Antimicrob Agents Chemother; 2006 Jun 30; 50(6):2079-86. PubMed ID: 16723569
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of nelfinavir in children: influencing factors and dose implications.
    Bergshoeff AS, Fraaij PL, van Rossum AM, Wolfs TF, Geelen SP, de Groot R, Burger DM.
    Antivir Ther; 2003 Jun 30; 8(3):215-22. PubMed ID: 12924538
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients.
    Boyd M, Mootsikapun P, Burger D, Chuenyam T, Ubolyam S, Mahanontharit A, Sangkote J, Bunyaprawit P, Horsakulchai M, Lange J, Cooper D, Phanuphak P, Ruxrungtham K.
    Antivir Ther; 2005 Jun 30; 10(2):301-7. PubMed ID: 15865224
    [Abstract] [Full Text] [Related]

  • 14. Intracellular and plasma pharmacokinetics of saquinavir-ritonavir, administered at 1,600/100 milligrams once daily in human immunodeficiency virus-infected patients.
    Ford J, Boffito M, Wildfire A, Hill A, Back D, Khoo S, Nelson M, Moyle G, Gazzard B, Pozniak A.
    Antimicrob Agents Chemother; 2004 Jul 30; 48(7):2388-93. PubMed ID: 15215085
    [Abstract] [Full Text] [Related]

  • 15. Are plasma levels valid surrogates for cellular concentrations of antiretroviral drugs in HIV-infected patients?
    Colombo S, Telenti A, Buclin T, Furrer H, Lee BL, Biollaz J, Decosterd LA, Swiss HIV Cohort Study.
    Ther Drug Monit; 2006 Jun 30; 28(3):332-8. PubMed ID: 16778716
    [Abstract] [Full Text] [Related]

  • 16. Effects of nelfinavir and its M8 metabolite on lymphocyte P-glycoprotein activity during antiretroviral therapy.
    Donahue JP, Dowdy D, Ratnam KK, Hulgan T, Price J, Unutmaz D, Nicotera J, Raffanti S, Becker M, Haas DW.
    Clin Pharmacol Ther; 2003 Jan 30; 73(1):78-86. PubMed ID: 12545146
    [Abstract] [Full Text] [Related]

  • 17. Lack of pharmacokinetic drug interaction between tenofovir disoproxil fumarate and nelfinavir mesylate.
    Boffito M, Pozniak A, Kearney BP, Higgs C, Mathias A, Zhong L, Shah J.
    Antimicrob Agents Chemother; 2005 Oct 30; 49(10):4386-9. PubMed ID: 16189129
    [Abstract] [Full Text] [Related]

  • 18. Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus.
    Chappuy H, Tréluyer JM, Rey E, Dimet J, Fouché M, Firtion G, Pons G, Mandelbrot L.
    Am J Obstet Gynecol; 2004 Aug 30; 191(2):558-62. PubMed ID: 15343237
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients.
    Burger D, Boyd M, Duncombe C, Felderhof M, Mahanontharit A, Ruxrungtham K, Ubolyam S, Stek M, Cooper D, Lange J, Phanupak P, Reiss P.
    J Antimicrob Chemother; 2003 May 30; 51(5):1231-8. PubMed ID: 12668574
    [Abstract] [Full Text] [Related]

  • 20. Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen.
    Isaac A, Taylor S, Cane P, Smit E, Gibbons SE, White DJ, Drake SM, Khoo S, Back DJ.
    J Antimicrob Chemother; 2004 Aug 30; 54(2):498-502. PubMed ID: 15254024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.